All terms in GO

Label Id Description
regulation of tube size, open tracheal system GO_0035151 [Ensuring that an epithelial tube in an open tracheal system is of the correct length and diameter. Tracheal tubes undergo highly regulated tube-size increases during development, expanding up to 40 times their initial size by the end of larval life. Tube size appears to be controlled by regulation of apical membrane expansion and secretion, rather than by changes in cell number, size or shape.]
somatotropin secreting cell development GO_0060133 [The process whose specific outcome is the progression of a somatotropin secreting cell over time, from its formation to the mature structure. A somatotropin secreting cell is an acidophilic cell of the anterior pituitary that produces growth hormone, somatotropin.]
negative regulation of terminal cell fate specification, open tracheal system GO_0035155 [Any process that restricts, stops or prevents a cell from adopting a terminal cell fate in an open tracheal system. Once the terminal and fusion fates have been correctly induced, inhibitory feedback loops prevent the remaining branch cells from assuming similar fates.]
prepulse inhibition GO_0060134 [The process in which a startle magnitude is reduced when the startling stimulus is preceded by a low-intensity prepulse.]
fusion cell fate specification GO_0035156 [The process in which a cell becomes capable of differentiating autonomously into a fusion cell in an environment that is neutral with respect to the developmental pathway; upon specification, the cell fate can be reversed. Fusion cells allow the interconnection of adjacent tracheal metameres during tracheal tube fusion.]
epithelial cell type specification, open tracheal system GO_0035153 [Allocation of epithelial cells within each migrating branch in an open tracheal system to distinct tracheal cell fates. During the migration phase each branch forms a well-defined number of cell types (including fusion cells, terminal cells and branch cells) at precise positions.]
GO_0060139 GO_0060139
maternal process involved in parturition GO_0060137 [A reproductive process occurring in the mother that results in birth.]
regulation of tube length, open tracheal system GO_0035159 [Ensuring that a tube in an open tracheal system is of the correct length.]
fetal process involved in parturition GO_0060138 [A reproductive process occurring in the embryo that results in birth.]
positive regulation of antibody-dependent cellular cytotoxicity GO_0001815 [Any process that activates or increases the frequency, rate or extent of antibody-dependent cellular cytotoxicity.]
regulation of antibody-dependent cellular cytotoxicity GO_0001813 [Any process that modulates the frequency, rate, or extent of antibody-dependent cellular cytotoxicity.]
FYXD domain binding GO_0098750 [Binding to a FXYD domain.]
negative regulation of antibody-dependent cellular cytotoxicity GO_0001814 [Any process that stops, prevents, or reduces the rate of antibody-dependent cellular cytotoxicity.]
bone cell development GO_0098751 [The process whose specific outcome is the progression of a bone cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.]
terminal cell fate specification, open tracheal system GO_0035154 [The process in which a cell in an open tracheal system becomes capable of differentiating autonomously into a terminal cell in an environment that is neutral with respect to the developmental pathway; upon specification, the cell fate can be reversed. Terminal cells send long and bifurcated hollow branches toward target tissues to allow oxygen exchange.]
negative regulation of type I hypersensitivity GO_0001811 [Any process that stops, prevents, or reduces the rate of type I hypersensitivity, a type of inflammatory response.]
regulation of type I hypersensitivity GO_0001810 [Any process that modulates the frequency, rate, or extent of type I hypersensitivity, a type of inflammatory response.]
negative regulation of hypersensitivity GO_0002884 [Any process that stops, prevents, or reduces the frequency, rate, or extent of hypersensitivity.]
obsolete integral component of the cytoplasmic side of the plasma membrane GO_0098752 [OBSOLETE. The component of the plasma membrane consisting of the gene products that penetrate only the cytoplasmic side of the membrane.]